GlassScriptPhysician profile
Tina Agostinelli
NPI 1528621885
$2,388.07
in general payments reported to CMS, 2019-2025
24 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,000 · 2022: $711 · 2023: $321 · 2024: $90.08 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $480.94 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $405.83 | 2021-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $350.43 | 2021-2025 | Airsupra |
| Abbvie INC. | $260.56 | 2021-2023 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $145.22 | 2021-2023 | Jardiance, Emgality |
| Biohaven Pharmaceuticals, INC. | $113.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.08 | 2021-2022 | |
| Pfizer INC. | $76.06 | 2021 | |
| Astellas Pharma US INC | $46.67 | 2021 | |
| Almatica Pharma LLC | $45.82 | 2022 | |
| Glaxosmithkline, LLC. | $43.23 | 2021-2022 | |
| Amarin Pharma, INC. | $40.97 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.86 | 2021 | |
| Acerus Pharmaceuticals Corporation | $34.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $31.93 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $23.09 | 2022 | |
| Esperion Therapeutics, INC. | $21.78 | 2021 | |
| Paratek Pharmaceuticals, INC. | $21.08 | 2022 | |
| Bausch Health US, LLC | $20.12 | 2021 | |
| Amneal Pharmaceuticals LLC | $19.97 | 2021 | |
| Medtronic, INC. | $18.33 | 2022 | |
| Jazz Pharmaceuticals INC. | $17.59 | 2021 | |
| Eisai INC. | $15.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Agostinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.